Iroda Jurabekova Has Been Appointed Executive Director of Global Market Access of Oncology at Boehringer Ingelheim
Iroda Jurabekova, Executive Director of Global Market Access of Oncology at Boehringer Ingelheim, shared a post on LinkedIn:
“I’m thrilled to share that I’ve stepped into a new role as Executive Director, Global Market Access, Oncology at Boehringer Ingelheim!
Grateful to brilliant people, colleagues, and friends I work with every day. Thankful to Itziar Canamasas, Evelyn Fahrenkrug, Ioannis Sapountzis, Robert Palmer, Bjoern Lutze, and many leaders and mentors who placed their trust in me – for seeing potential before titles, and for supporting my growth with integrity and vision.
Access is a commitment to patients, to science, and to future possibilities.
To the teams we work with and the patients we work for, we carry this responsibility with purpose and pride. Forward.”
Explore more career and achievement stories on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023